Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were classified into two cohorts based on their serum 25-hydroxyvitamin D (25 [OH] D) levels.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis

Study design awaiting verification · Frontiers in Nutrition · 2026

Original publication title

Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis

Ying-Jen Chang; Hsiu-Lan Weng; Kuo-Chuan Hung; Chun-Ning Ho; Yi-Chen Lai; Jheng-Yan Wu; I-Wen Chen

Copyright © 2026 Chang, Weng, Hung, Ho, Lai, Wu and Chen.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among adults with OSA, vitamin D deficiency was linked to a markedly higher risk of developing heart failure as well as other unfavorable cardiopulmonary events, and this association demonstrated a clear dose: response pattern. These findings suggest that vitamin D status may represent an important factor in cardiovascular risk stratification in patients with OSA.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients. However, whether vitamin D deficiency is associated with an elevated risk of heart failure, specifically within the OSA population, remains unclear.

Source: Background

Abstract: What methods does the paper describe?

We conducted a retrospective cohort analysis using data from the TriNetX Global Collaborative Network (2010 to 2022) to investigate whether vitamin D deficiency, defined as a 25-hydroxyvitamin D concentration < 20 ng/mL, is associated with new-onset heart failure in adults diagnosed with OSA. Patients with sufficient vitamin D levels (≥30 ng/mL) served as controls. Propensity score matching (1:1) was performed to balance the baseline characteristics. The primary outcome was incident heart failure; secondary outcomes included all-cause mortality, secondary pulmonary hypertension, primary pulmonary hypertension, and pulmonary embolism at the 5-year follow-up.

Source: Methods

Abstract: Results

After propensity score matching, 36,497 patients were included in each cohort. Vitamin D deficiency was significantly associated with a higher risk of heart failure (HR 1.45; 95% CI 1.37 to 1.53; p < 0.001), all-cause mortality (HR 1.76; 95% CI 1.64 to 1.89; p < 0.001), secondary pulmonary hypertension (HR 1.25; 95% CI 1.13 to 1.38; p < 0.001), and pulmonary embolism (HR 1.31; 95% CI 1.17 to 1.47; p < 0.001). No significant association was observed with primary pulmonary hypertension (HR 1.22; 95% CI 0.84 to 1.79; p = 0.300).

Dose-response analysis revealed attenuated associations for vitamin D insufficiency (20 to 29.9 ng/mL). Subgroup analyses demonstrated a stronger association among obese patients (p for interaction = 0.028).

Source: Results

Abstract: Conclusion

Among adults with OSA, vitamin D deficiency was linked to a markedly higher risk of developing heart failure as well as other unfavorable cardiopulmonary events, and this association demonstrated a clear dose: response pattern. These findings suggest that vitamin D status may represent an important factor in cardiovascular risk stratification in patients with OSA.

Source: Conclusion
Authors’ abstract

Background

Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients. However, whether vitamin D deficiency is associated with an elevated risk of heart failure, specifically within the OSA population, remains unclear.

Methods

We conducted a retrospective cohort analysis using data from the TriNetX Global Collaborative Network (2010 to 2022) to investigate whether vitamin D deficiency, defined as a 25-hydroxyvitamin D concentration < 20 ng/mL, is associated with new-onset heart failure in adults diagnosed with OSA. Patients with sufficient vitamin D levels (≥30 ng/mL) served as controls. Propensity score matching (1:1) was performed to balance the baseline characteristics. The primary outcome was incident heart failure; secondary outcomes included all-cause mortality, secondary pulmonary hypertension, primary pulmonary hypertension, and pulmonary embolism at the 5-year follow-up.

Results

After propensity score matching, 36,497 patients were included in each cohort. Vitamin D deficiency was significantly associated with a higher risk of heart failure (HR 1.45; 95% CI 1.37 to 1.53; p < 0.001), all-cause mortality (HR 1.76; 95% CI 1.64 to 1.89; p < 0.001), secondary pulmonary hypertension (HR 1.25; 95% CI 1.13 to 1.38; p < 0.001), and pulmonary embolism (HR 1.31; 95% CI 1.17 to 1.47; p < 0.001). No significant association was observed with primary pulmonary hypertension (HR 1.22; 95% CI 0.84 to 1.79; p = 0.300).

Dose-response analysis revealed attenuated associations for vitamin D insufficiency (20 to 29.9 ng/mL). Subgroup analyses demonstrated a stronger association among obese patients (p for interaction = 0.028).

Conclusion

Among adults with OSA, vitamin D deficiency was linked to a markedly higher risk of developing heart failure as well as other unfavorable cardiopulmonary events, and this association demonstrated a clear dose: response pattern. These findings suggest that vitamin D status may represent an important factor in cardiovascular risk stratification in patients with OSA.

Publication and source details

Original title: Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis

Ying-Jen Chang; Hsiu-Lan Weng; Kuo-Chuan Hung; Chun-Ning Ho; Yi-Chen Lai; Jheng-Yan Wu; I-Wen Chen

Frontiers in Nutrition · 2026

* Correspondence: I-Wen Chen, cheniwena60912@gmail.com
†

These authors have contributed equally to this work

Copyright © 2026 Chang, Weng, Hung, Ho, Lai, Wu and Chen.2026Chang, Weng, Hung, Ho, Lai, Wu and Chenhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:59:25.353706+00:00

DOI: 10.3389/fnut.2026.1755607 · PMC12960163